HER2 Blockade: Is Combination Therapy Better Than Monotherapy?

By Hirsh Rebecca  

Current Treatment Options in Oncology, Vol. 11, Iss. 3-4, 2010-12 ,pp. : 63-65

Springer Publishing Company

Access to resources Recommend Favorite

A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer

By Hoshi Senji   Yamaguchi Osamu   Fujioka Tomoaki   Arai Yoichi   Tomita Yoshihiko   Habuchi Tomonori   Ohyama Chikara   Suzuki Tadashi   Orikasa Seiichi  

International Journal of Clinical Oncology, Vol. 11, Iss. 4, 2006-08 ,pp. : 303-308

Springer Publishing Company

Access to resources Recommend Favorite

A randomized comparative study of endocrine monotherapy and a combination of estramustine phosphate with the endocrine therapy in patients with untreated stage D prostate cancer

By Hoshi Senji   Yamaguchi Osamu   Fujioka Tomoaki   Arai Yoichi   Tomita Yoshihiko   Habuchi Tomonori   Ohyama Chikara   Suzuki Tadashi   Orikasa Seiichi  

International Journal of Clinical Oncology, Vol. 11, Iss. 6, 2006-12 ,pp. : 492-493

Springer Publishing Company

Access to resources Recommend Favorite

Molecular targeted therapies for cancer: Sorafenib mono­therapy and its combination with other therapies (Review)

By        

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1303-1311

Spandidos Publications

Access to resources Recommend Favorite

Efficacy and safety of sitagliptin compared with sulfonylurea therapy in patients with type 2 diabetes showing inadequately controlled glycosylated hemoglobin with metformin monotherapy: A meta-analysis

By        

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1528-1536

Spandidos Publications

Access to resources Recommend Favorite